The therapeutic potential of centrally acting dopamine agonists
- 31 December 1984
- journal article
- editorial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 5, 227-230
- https://doi.org/10.1016/0165-6147(84)90427-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrainActa Physiologica Scandinavica, 1982
- Troponoid. V. Crystallographic studies on AY-27110 — a dopamine agonist of the troponylpiperazine seriesCanadian Journal of Chemistry, 1982
- Clonidine treatment of schizophreniaActa Psychiatrica Scandinavica, 1982
- Biphasic influence of a 8α-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the ratLife Sciences, 1981
- Evidence that LY-141865 specifically stimulates the D-2 dopamine receptorNature, 1981
- Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor AgonistScience, 1979
- The effect of dopamine and of apomorphine on dB-cAMP-induced stimulation of synaptosomal tyrosine hydroxylaseJournal of Pharmacy and Pharmacology, 1974
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972
- The inhibition of catecholamine biosynthesis by apomorphineJournal of Pharmacy and Pharmacology, 1970
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960